From VOCs to Diagnostic Insights
From VOCs to Diagnostic Insights: The Technology Behind BreathBase
Breath analysis is transforming the way we think about diagnostics. Imagine detecting early-stage diseases or predicting treatment responses through a simple, non-invasive breath test. This is no longer science fiction but a reality enabled by technologies like the SpiroNose and BreathBase platform developed by Breathomix. At the heart of this innovation lies the ability to detect and interpret volatile organic compounds (VOCs) in human breath. But how exactly does this work?
What are VOCs?
Volatile organic compounds (VOCs) are tiny molecules that evaporate at room temperature, making them detectable in the air we exhale. They originate from various sources, both inside and outside the human body:
- Internal sources: VOCs are byproducts of metabolic processes, such as digestion, cellular respiration, and immune responses. For instance, inflammation or tumor growth can alter metabolic pathways, leading to specific VOC changes.
- External sources: Environmental factors like pollution, diet, and exposure to chemicals can influence VOC composition in breath. For example, certain foods or medications may introduce new VOCs or amplify existing ones.
Each person’s breath contains a unique VOC-profile—a chemical fingerprint influenced by health, lifestyle, and environment. Diseases such as lung cancer or inflammatory conditions alter this fingerprint, creating specific VOC patterns. Detecting these changes can provide valuable diagnostic insights.
Unlike traditional biomarkers, VOCs form complex patterns rather than isolated signals. These patterns, collectively referred to as VOC-profiles, provide a comprehensive view of physiological and pathological changes in the body. BreathBase leverages these profiles to identify composite biomarkers—clusters of VOCs that together signify a particular disease or condition.
How MOS Sensors Detect VOCs
Metal-oxide semiconductor (MOS) sensors operate based on changes in the electrical resistance of a sensing material when exposed to VOCs. The core components of a MOS sensor include:
- Sensing Layer: Made of metal oxides like tin oxide (SnO₂) or zinc oxide (ZnO), this layer interacts with gas molecules.
- Heater Element: Maintains the sensor at an optimal temperature to enhance VOC interactions.
- Electrodes: Measure changes in resistance caused by VOC interactions.
When VOCs are present in exhaled breath:
- Adsorption: VOC molecules adsorb onto the surface of the metal-oxide sensing layer.
- Chemical Reaction: These molecules react with oxygen ions on the sensor surface, altering the concentration of free electrons in the metal oxide.
- Resistance Change: The chemical reaction causes a measurable change in the electrical resistance of the sensor.
- Signal Generation: This resistance change generates a unique signal pattern that corresponds to the VOC mixture in the sample.
Cross-Reactivity: A Feature, Not a Bug
Unlike single-compound sensors that target specific molecules, MOS sensors are cross-reactive. This means they respond to a range of VOCs based on shared chemical properties, such as functional groups, polarity, or molecular weight. While they cannot identify individual VOCs, their cross-reactive nature is crucial for detecting complex VOC-profiles.
The SpiroNose utilizes an array of MOS sensors, each with a different sensitivity profile. Together, these sensors produce overlapping signals that form a composite pattern—a chemical fingerprint of the VOC mixture in the breath.
This approach eliminates the need to identify individual VOCs, which can be challenging given the complexity of breath samples. Instead, the strength of the SpiroNose lies in combining cross-reactive MOS sensors with advanced pattern recognition algorithms in the BreathBase platform. This combination enables highly accurate detection of disease-specific VOC-profiles.
Advantages of MOS Sensors in Breath Analysis
- High Sensitivity: MOS sensors can detect VOCs at low concentrations (parts per million or parts per billion).
- Broad Detection Range: Their cross-reactivity allows them to capture the diverse and dynamic nature of VOCs in breath.
- Robustness: MOS sensors are durable and capable of operating in various environmental conditions, making them suitable for clinical applications.
- Cost-Effectiveness: Compared to more complex technologies like mass spectrometry, MOS sensors offer an affordable solution for breath analysis.
From Signals to Diagnostic Insights
The raw data generated by MOS sensors are only the first step in the diagnostic process. The true power of VOC detection comes from BreathBase, which processes and interprets these signals.
- Signal Preprocessing: Raw signals undergo noise reduction and normalization to ensure consistent data quality.
- Feature Extraction: VOC patterns are analyzed to identify features associated with specific diseases.
- Composite Biomarker Analysis: By focusing on clusters of VOCs, BreathBase identifies composite biomarkers indicative of disease states.
- Machine Learning Models: Advanced algorithms compare the extracted features against a growing reference database of breath profiles.
- Diagnostic Output: The platform generates a predictive score, assisting clinicians in decision-making.
Decades of research have shown that this integrated approach—cross-reactive sensing combined with powerful computational analysis—results in higher diagnostic accuracy compared to single-compound detection methods.
Why VOCs Are Ideal for Diagnostics
VOCs offer unique advantages as diagnostic markers:
- Non-Invasiveness: Breath analysis eliminates the need for blood draws or invasive procedures.
- Dynamic Monitoring: VOCs reflect real-time metabolic changes, enabling continuous tracking of disease progression or treatment response.
- Broad Applications: VOC-profiles can detect respiratory diseases, metabolic disorders, and infections, among others.
As breath analysis advances, its applications continue to expand:
- Early Detection: Identifying diseases like lung cancer at treatable stages.
- Treatment Monitoring: Providing real-time feedback on therapy effectiveness.
- Precision Medicine: Customizing treatments based on individual VOC-profiles.
A New Frontier in Diagnostics
As BreathBase continues to evolve, it is unlocking new possibilities in precision medicine. By making breath analysis as routine as blood testing, Breathomix envisions a future where non-invasive diagnostics are the standard of care. With applications expanding beyond respiratory diseases to include metabolic and infectious conditions, the journey from VOCs to diagnostic insights is just beginning. Stay tuned as we continue to push the boundaries of what breath analysis can achieve.
References
- Mazzatenta A, Pokorski M, Di Giulio C. Volatile organic compounds (VOCs) in exhaled breath as a marker of hypoxia in multiple chemical sensitivity. Physiol Rep. 2021 Sep;9(18):e15034. doi: 10.14814/phy2.15034. PMID: 34536058; PMCID: PMC8449310.
- Yilu Gao, Baoqing Chen, Xingyuan Cheng, Shiliang LiuD, Qiaoqiao Li, Mian Xi. Volatile organic compounds in exhaled breath: Applications in cancer diagnosis and predicting treatment efficacy. Cancer Pathogenesis and Therapy, 2025
- de Vries R, Sterk PJ. eNose breathprints as composite biomarker for real-time phenotyping of complex respiratory diseases. J Allergy Clin Immunol. 2020 Nov;146(5):995-996. doi: 10.1016/j.jaci.2020.07.022. Epub 2020 Jul 31. PMID: 32745557.